Medical biotechnology industry

Passengers from the Grand Princess, a cruise ship carrying multiple people who have tested positive for COVID-19, exit a bus before boarding a chartered plane in Oakland, Calif., Tuesday, March 10, 2020. The passengers on the flight are going to San Antonio to be quarantined at Lackland Air Force Base. (AP Photo/Jeff Chiu)
SKY News
March 11, 2020 - 12:12 am
Alarming clusters of the coronavirus swelled on both coasts of the U.S. on Tuesday, with more than 70 cases now tied to a biotech conference in Boston and infections turning up at 10 nursing homes in the hard-hit Seattle area. Presidential candidates Bernie Sanders and Joe Biden abruptly canceled...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 12:03 am
BEIJING (AP) — China has unveiled draft regulations on gene-editing and other potentially risky new biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology...
Read More
February 25, 2019 - 7:32 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. The mostly-cash transaction is expected to...
Read More
FILE- In this Nov. 20, 2018, file photo pedestrians walk past the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Nov. 30 (AP Photo/Mary Altaffer, File)
November 30, 2018 - 1:51 pm
NEW YORK (AP) — Stocks are wavering Friday ahead of the highly anticipated trade meeting between President Donald Trump and President Xi Jinping of China. Investors have long hoped the two will use their meeting at the Group of 20 summit to start resolving the trade dispute between the two...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 2:17 am
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8:20 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 12:24 am
NEW YORK (AP) — Republican U.S. Rep. Christopher Collins of New York was arrested Wednesday on charges he fed inside information he gleaned from sitting on the board of a biotechnology corporation to his son, helping family and friends dodge hundreds of thousands of dollars in losses when one of...
Read More